G547-0693 Screening compound: N~4~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-2-(3-pyridyl)-4-quinolinecarboxamide

G547-0693 Screening compound: N~4~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-2-(3-pyridyl)-4-quinolinecarboxamide
G547-0693 Screening compound: N~4~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-2-(3-pyridyl)-4-quinolinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G547-0693
N~4~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-2-(3-pyridyl)-4-quinolinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G547-0693

Molecular Formula

C19H17N3O3S (C19 H17 N3 O3 S)

Compound Name

N~4~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-2-(3-pyridyl)-4-quinolinecarboxamide

IUPAC name

N-(11-dioxo-1lambda6-thiolan-3-yl)-2-(pyridin-3-yl)quinoline-4-carboxamide

SMILES

O=C(c1cc(-c2cnccc2)nc2ccccc12)NC(CC1)CS1(=O)=O

InChI

InChI=1S/C19H17N3O3S/c23-19(21-14-7-9-26(24,25)12-14)16-10-18(13-4-3-8-20-11-13)22-17-6-2-1-5-15(16)17/h1-6,8,10-11,14H,7,9,12H2,(H,21,23)/t14-/m1/s1

InChI Key

CWIJZOSCCMGUMG-CQSZACIVSA-N

MDL Number (MFCD)

MFCD11763012

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

367.43

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.741

Distribution Coefficient, logD

1.738

Water Solubility, LogSw

-2.45

Polar Surface Area

70.391

Acid Dissociation Constant (pKa)

16.13

Base Dissociation Constant (pKb)

5.15

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

21.10

G547-0693 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Angiogenesis library (14822 compounds)

Anti-Aging Library (44940 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Targeted Diversity Library (40567 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Nervous system
  • Cardiovascular
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • Nuclear receptors
  • Ion Channels

References: we are preparing a list of scientific research reports with G547-0693 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G547-0693?
Check Price and Availability of G547-0693, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G547-0693 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G547-0693
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G547-0693
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G547-0693 available by request